Novel formulations and modes of delivery of levodopa

Population Pharmacodynamics of IPX066: An Oral Extended-Release Capsule Formulation of Carbidopa-Levodopa, and Immediate-Release Carbidopa-Levodopa in Patients With Advanced Parkinson's Disease

(2013) Zhongping Mao et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Effect and safety of duodenal levodopa infusion in advanced Parkinson’s disease: a retrospective multicenter outcome assessment in patient routine care

(2013) A. Antonini et al.   JOURNAL OF NEURAL TRANSMISSION

Efficacy and safety of opicapone, a new COMT-inhibitor, for the treatment of motor fluctuations in Parkinson's Disease patients: BIPARK-II study

(2013) A. Lees et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial

(2013) Robert A Hauser et al.   LANCET NEUROLOGY

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

(2013) C Warren Olanow et al.   LANCET NEUROLOGY

Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease

(2013) Peter A. LeWitt et al.   MOVEMENT DISORDERS

Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results

(2013) Hubert H. Fernandez et al.   PARKINSONISM & RELATED DISORDERS

Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens

(2013) F. Mancini et al.   PARKINSONISM & RELATED DISORDERS

Pharmacokinetics of Levodopa/Carbidopa Microtablets Versus Levodopa/Benserazide and Levodopa/Carbidopa in Healthy Volunteers

(2012) Dag Nyholm et al.   CLINICAL NEUROPHARMACOLOGY

Actively Transported Levodopa Prodrug XP21279

(2012) Peter A. LeWitt et al.   CLINICAL NEUROPHARMACOLOGY

Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease

(2012) Lissa S. Brod et al.   MOVEMENT DISORDERS

Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease

(2011) Robert A. Hauser et al.   MOVEMENT DISORDERS

Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study

(2010) Fabrizio Stocchi et al.   ANNALS OF NEUROLOGY

Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinsonʼs Disease

(2010) Angelo Antonini et al.   CNS DRUGS

Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life

(2009) Holger Honig et al.   MOVEMENT DISORDERS

Evidence-Based Efficacy Comparison of Tolcapone and Entacapone as Adjunctive Therapy in Parkinson's Disease

(2008) Andrew J. Lees   CNS Neuroscience & Therapeutics

Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study

(2008) Pedro J. García Ruiz et al.   MOVEMENT DISORDERS

Neuropathy as a potential complication of levodopa use in Parkinson's disease

(2008) Cory Toth et al.   MOVEMENT DISORDERS